Resuscitation Plus (Mar 2024)

Design and implementation of the hospital airway resuscitation trial

  • Ari Moskowitz,
  • Luke Andrea,
  • Ariel L. Shiloh,
  • John Cardasis,
  • Colleen Carty,
  • Mimi Kim,
  • Xianhong Xie,
  • Susan McAllen,
  • David Esses,
  • Carlo Lutz,
  • Mai Takematsu,
  • Jose Romero,
  • Kristen Schimmrich,
  • Daniel G. Fein,
  • Amos E. Dodi,
  • Samuel Rednor,
  • Maneesha Bangar,
  • Amira Mohamed,
  • Lewis A. Eisen,
  • Henry E. Wang,
  • Michael W. Donnino,
  • Michelle Ng Gong

Journal volume & issue
Vol. 17
p. 100512

Abstract

Read online

Guidelines for the management of in-hospital cardiac arrest resuscitation are often drawn from evidence generated in out-of-hospital cardiac arrest populations and applied to the in-hospital setting. Approach to airway management during resuscitation is one example of this phenomenon, with the recommendation to place either a supraglottic airway or endotracheal tube when performing advanced airway management during in-hospital cardiac arrest based mainly in clinical trials conducted in the out-of-hospital setting. The Hospital Airway Resuscitation Trial (HART) is a pragmatic cluster-randomized superiority trial comparing a strategy of first choice supraglottic airway to a strategy of first choice endotracheal intubation during resuscitation from in-hospital cardiac arrest. The design includes a number of innovative elements such as a highly pragmatic design drawing from electronic health records and a novel primary outcome measure for cardiac arrest trials—alive-and-ventilator free days. Many of the topics explored in the design of HART have wide relevance to other trials in in-hospital cardiac arrest populations.

Keywords